|Bid||24.90 x 800|
|Ask||24.92 x 1000|
|Day's Range||24.25 - 25.09|
|52 Week Range||5.10 - 53.90|
|Beta (5Y Monthly)||1.87|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 06, 2021 - Jul 12, 2021|
|Forward Dividend & Yield||0.68 (17.94%)|
|Ex-Dividend Date||Mar 12, 2020|
|1y Target Est||26.23|
For his second "Executive Decision" segment of Wednesday's Mad Money program, host Jim Cramer spoke with Mark Tritton, president and CEO of Bed Bath & Beyond , the home goods retailer. Tritton said he's been encouraged by their performance as more and more stores reopen. Tritton was also upbeat about the company's Bye Bye Baby franchise .
By Jarrett Banks Roumell Asset Management LLC filed an amended 13D on Enzo Biochem Inc. expressing its disapproval that the company hasn’t accepted Co-Founder Elazar Rabbani’s board resignation. Enzo Biochem, Inc., founded in the 1970s, has frustrated investors with a poor operational and share-price performance over the last several years. CorpGov has covered the story extensively. “Shareholders demonstrated […]
What happened Bed Bath & Beyond (NASDAQ: BBBY) shares dropped by 13% in April, according to data provided by S&P Global Market Intelligence -- a particularly lackluster performance given the 5.2% spike that the S&P 500 registered for the month.